Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.32 CAD 0.01 ( 4.92%)
Last update at 2026-11-03T19:25:00Z
VOLUME
14322
Market Cap
134.85M

Momentum Score

…

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products. Its product categories include full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushrooms; and pet products under the Charlotte's Web, CBD CLINIC, and CBD MEDIC brand names. The company's products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. It distributes its products through retail outlets, health care practitioners, and distributors, as well as online through its website and other third-party e-commerce sites. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.31
Low
0.32
High
52 Week Price Range
0.11
Low
1.33
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Charlotte's Web Holdings Inc produces and sells hemp-derived CBD wellness products for people and pets via direct-to-consumer and retail channels. Long-term growth drivers include rising consumer adoption of CBD, product innovation and expansion into new channels and markets, and the company's established brand may support distribution reach.

Key risks are regulatory uncertainty over CBD ingestibles, strong competition from larger consumer packaged goods players, and commodity and margin pressure.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.30
Dividend Yield
-
Revenue TTM
49.90M
Revenue Per Share
0.31
Gross Profit TTM
21.70M
Debt / Equity
-31.61
ROE
-237.47%
Net Debt
56.42M
ROCE
-30.43%
Diluted EPS TTM
-0.26

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -29.81M -29.81M -23.27M -59.22M -137.58M
Net income -29.74M -29.85M -23.80M -59.31M -137.72M
Selling general administrative 41.97M 41.58M 61.85M 65.80M 91.12M
Selling and marketing expenses - 7.98M 13.78M - -
Gross profit 21.70M 21.26M 35.57M 19.41M 48.59M
Reconciled depreciation 6.32M 9.98M 15.16M 8.97M 11.03M
Ebit -20.27M -31.99M -40.06M -50.65M 39.52M
Ebitda -13.95M -22.01M -24.90M -32.36M 50.54M
Depreciation and amortization 6.32M 9.98M 15.16M 18.29M 11.03M
Operating income -20.27M -31.99M -40.61M -50.65M 39.52M
Other operating expenses 70.17M 81.65M 103.77M 124.79M 145.15M
Interest expense - - - 17.89M 177.10M
Tax provision -0.07M 0.04M 0.53M 0.09M 0.14M
Interest income - 0.61M 20.04M 7.48M 9.43M
Income tax expense -0.07M 0.04M 0.53M 0.09M 0.14M
Total revenue 49.90M 49.67M 63.16M 74.14M 96.09M
Total operating expenses 41.97M 53.25M 76.18M 70.06M 97.64M
Cost of revenue 28.20M 28.41M 27.59M 54.73M 47.51M
Total other income expense net -9.54M 2.18M 17.34M -8.57M -177.10M
Net income from continuing ops -29.74M -29.85M -23.80M -59.31M -137.72M
Net income applicable to common shares - -29.85M -23.80M -59.31M -137.72M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 75.27M 113.44M 152.55M 187.64M 171.51M
Intangible assets 0.79M 14.74M 17.96M 28.64M 2.84M
Other current assets 1.77M 1.00M 2.50M 2.50M 7.15M
Total liab 77.31M 86.36M 96.99M 110.14M 41.07M
Total stockholder equity -2.04M 27.09M 55.56M 77.50M 130.45M
Other current liab 5.05M - 20.79M 15.10M 13.02M
Common stock 0.00M - 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -331.31M -301.57M -271.72M -247.93M -188.61M
Other liab - - - - 0.40M
Good will - - - - 0.00M
Other assets - - - 9.39M 16.10M
Cash 8.04M 22.62M 47.82M 66.96M 19.49M
Cash and equivalents - - - 66.96M 19.49M
Total current liabilities 8.66M 15.94M 23.65M 21.43M 20.17M
Current deferred revenue - - -2.25M - -
Net debt 56.42M 21.01M 12.62M -9.33M 3.11M
Short term debt 1.42M - 2.25M 2.31M 2.10M
Short long term debt total 64.45M - 60.44M 57.63M 22.60M
Other stockholder equity 329.27M - 327.28M 325.43M 319.06M
Property plant equipment - - - 45.85M 56.76M
Total current assets 30.36M 46.98M 78.17M 103.76M 95.81M
Long term investments 8.80M 10.80M 11.00M - 13.00M
Net tangible assets - - - 48.86M 127.60M
Short term investments - - 1.17M - -
Net receivables 2.54M 1.26M 2.33M 2.42M 17.09M
Long term debt 50.85M 43.63M 42.53M 37.43M 0.39M
Inventory 18.02M 18.91M 21.54M 26.95M 52.08M
Accounts payable 2.19M 3.43M 2.86M 4.02M 5.05M
Accumulated other comprehensive income - - 0.00M - -
Non currrent assets other 1.35M 0.63M 0.70M 9.39M 3.10M
Non current assets total 44.91M 79.34M 74.38M 83.88M 75.71M
Capital lease obligations 13.61M 15.71M 17.91M 20.21M 22.60M
Long term debt total - - - 37.43M 20.89M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -3.80M -3.51M 0.40M -11.79M
Change to liabilities - - - 0.00M -2.91M
Total cashflows from investing activities -0.41M -3.80M -3.51M 0.40M -11.79M
Total cash from financing activities -0.05M -0.14M -0.25M 52.39M 8.04M
Change to operating activities - - - - -6.51M
Net income -29.74M -29.85M -23.80M -59.31M -137.72M
Change in cash -14.58M -25.20M -19.14M 47.47M -33.31M
Begin period cash flow 22.62M 47.82M 66.96M 19.49M 52.80M
End period cash flow 8.04M 22.62M 47.82M 66.96M 19.49M
Total cash from operating activities -14.12M -21.26M -15.39M -5.32M -29.56M
Issuance of capital stock - - - - 8.26M
Depreciation 6.32M 9.98M 15.16M 8.97M 11.03M
Other cashflows from investing activities 0.14M 0.06M 0.18M 0.66M -6.88M
Change to inventory 0.11M -1.52M 4.38M 1.73M 1.02M
Change to account receivables 0.37M 0.36M 3.45M 2.95M -0.95M
Sale purchase of stock - - - -0.06M 8.29M
Other cashflows from financing activities -0.05M -0.14M -0.25M 52.45M -0.22M
Change to netincome - - - - 105.81M
Capital expenditures 0.55M 3.85M 3.69M 0.27M 4.92M
Change in working capital -3.28M -9.07M -1.87M 4.77M -8.67M
Stock based compensation 0.66M 1.52M 2.10M 3.40M 5.48M
Other non cash items 11.91M 6.15M -6.98M 36.86M 100.33M
Free cash flow -14.67M -25.11M -19.08M -5.58M -34.48M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CWEB
Charlotte's Web Holdings Inc
0.01
4.92%
0.32 - 58.82 2.70 12.40 3.08 -2.70
CURA
Curaleaf Holdings Inc.
1.23
9.59%
14.06 - 138.89 2.57 3.14 2.47 13.10
BHC
Bausch Health Companies Inc
0.12
1.07%
11.37 13.98 1.35 0.28 18.74 2.12 6.84
CRON
Cronos Group Inc
0.06
1.28%
4.76 - 32.15 9.80 0.95 1.47 1.90
TLRY
Tilray Inc
0.13
3.66%
3.68 - 1000.00 1.28 0.53 1.08 -2.30

Profile*

Charlotte's Web Holdings Inc

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products. Its product categories include full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushrooms; and pet products under the Charlotte's Web, CBD CLINIC, and CBD MEDIC brand names. The company's products contain naturally occurring phytocannabinoids, including CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids, and other beneficial hemp compounds. It distributes its products through retail outlets, health care practitioners, and distributors, as well as online through its website and other third-party e-commerce sites. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Louisville, Colorado.

700 Tech Court, Louisville, CO, United States, 80027

720 484 8930

112

Name Title Year Born
Mr. Jacques Tortoroli CEO, Pres & Director 1959
Mr. Jared Stanley Co-Founder & COO 1988
Mr. Greg Gould CFO & Chief Admin. Officer NA
Mr. Andres de Gortari Chief Accounting Officer 1976
Cory Pala Director of Investor Relations NA
Mr. Stephen David Rogers Sr. VP, Gen. Counsel & ?Corp. Sec.. 1966
Ms. Kelly Shea Sr. VP of Gov. Affairs & Corp. Communications NA
Mr. Richard L. Mohr Advisor 1960
Mr. Tim Orr Sr. VP of Innovation NA
Mr. Perry Antelman Exec. VP & Pres of Topicals 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…